DI BELLA METHOD
>
DOCUMENTATION INDEX > MDB - Documents
Epidermal growth factor receptor, somatostatin and bcl-2 in human pancreatic tumor xenografts. An immunohistochemical study.
(30/05/2003)
Detail
Autocrine regulation of human prostate carcinoma cell proliferation by somatostatin through the modulation of the SH2 domain containing protein tyrosine phosphatase (SHP)-1.
(30/05/2003)
Detail
Regulation of targeted chemotherapy with cytotoxic lutenizing hormone-releasing hormone analogue by epidermal growth factor.
(30/05/2003)
Detail
Differential regulation of somatostatin receptor type 2 (sst 2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment.
(30/05/2003)
Detail
Regression of a distal bile duct carcinoma after treatment with octreotide for 6 months.
(30/05/2003)
Detail
[Radio-guided resection of residual metastatic lymph node from a previously resected neuroendocrine tumor]
(30/05/2003)
Detail
Occurrence and effects of octreotide antibodies during nasal, subcutaneous and slow release intramuscular treatment.
(30/05/2003)
Detail
Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide.
(30/05/2003)
Detail
Clinical relevance of somatostatin receptor scintigraphy in patients with skull base tumours
(30/05/2003)
Detail
Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours.
(30/05/2003)
Detail
Clinical and biochemical response following withdrawal of a long-acting, depot injection form of octreotide (Sandostatin-LAR).
(30/05/2003)
Detail
Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth.
(30/05/2003)
Detail
Somatostatin, its receptors and analogs, in lung cancer.
(30/05/2003)
Detail
The role of radioactive somatostatin and its analogues in the control of tumor growth.
(30/05/2003)
Detail